Cargando…
A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion
Hydralazine induced lupus syndrome (HILS), a form of Drug-Induced Lupus (DIL), was first reported in 1953. Since then, studies have shown an increasing incidence of HILS. It presents with lupus-like symptoms such as arthralgia, fever, chest pain, anorexia, fatigue, petechiae, and rash. Though rare,...
Autores principales: | Elkholy, Karim O, Akhtar, Hamza, Chakraborti, Abishek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495962/ https://www.ncbi.nlm.nih.gov/pubmed/32953340 http://dx.doi.org/10.7759/cureus.9831 |
Ejemplares similares
-
Hydralazine-Induced Lupus Syndrome Manifesting as Large Pericardial Effusion
por: Wilson, Nathaniel R, et al.
Publicado: (2020) -
ANA-Negative Hydralazine-Induced Pericardial Effusion
por: Zeitjian, Vicken, et al.
Publicado: (2017) -
Dasatinib-Induced Pleural and Pericardial Effusions
por: Hailan, Yousef M, et al.
Publicado: (2021) -
Pleural and Pericardial Effusion With COVID-19 and Systemic Lupus Erythematosus and Its Recurrence: A Case Study
por: Yost, Connor, et al.
Publicado: (2023) -
Pericardial Effusion and Progressive Bilateral Effusion as Rare Presentations of Idiopathic Hypereosinophilic Syndrome
por: Soma, Shunsuke
Publicado: (2023)